Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25 | 1 | 49 | 3 | 15 |
| TOTAL | $48 | $13 | $74 | $19 | $53 |
| Non-Current Assets | |||||
| PPE Net | 92 | 108 | 124 | 140 | 156 |
| Other Non-Current Assets | 0 | 0 | 12 | 12 | 12 |
| TOTAL | $92 | $108 | $136 | $152 | $168 |
| Total Assets | $141 | $121 | $210 | $170 | $220 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,861 | 1,884 | 1,870 | 1,818 | 1,719 |
| Accrued Expenses | 2,818 | 2,459 | 2,245 | 2,017 | 1,790 |
| Other current liabilities | 944 | 1,004 | 1,020 | 1,061 | 1,045 |
| TOTAL | $5,862 | $5,582 | $5,356 | $4,972 | $4,601 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 15 | 18 | 10 | N/A | N/A |
| Other Non-Current Liabilities | -28 | -29 | 364 | -44 | -43 |
| TOTAL | $N/A | $N/A | $10 | $21 | $24 |
| Total Liabilities | $5,862 | $5,582 | $5,366 | $4,994 | $4,625 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,434 | 14,399 | N/A | 14,374 | 14,374 |
| Common Shares | 601 | 601 | 601 | 601 | 601 |
| Retained earnings | -119,932 | -119,620 | -119,344 | -118,510 | -118,178 |
| Other shareholders' equity | -411 | -383 | -354 | -313 | -270 |
| TOTAL | $-5,721 | $-5,462 | $-5,156 | $-4,823 | $-4,404 |
| Total Liabilities And Equity | $141 | $121 | $210 | $170 | $220 |